Allogeneic Platform

Search documents
URGENT: The M&A Class Action Firm Launches Legal Inquiry for the Merger - CRGX, HSON, BRZH, and ENZB
Prnewswire· 2025-07-25 21:31
Group 1 - Class Action Attorney Juan Monteverde's firm has recovered millions for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report [1] - CARGO Therapeutics, Inc. is being investigated regarding its sale to Concentra Biosciences, LLC for $4.379 in cash per share, plus contingent value rights related to net cash and proceeds from specific therapies [1] - Hudson Global, Inc. is merging with Star Equity Holdings, Inc., with Hudson shareholders expected to own approximately 79% of the combined company post-transaction [1] - Breeze Holdings Acquisition Corp. is proposed to merge with YD Biopharma Limited, converting all ordinary shares into the right to receive shares of the surviving company [2] - Enzo Biochem, Inc. is selling to Battery Ventures for $0.70 per share in cash, with a shareholder vote scheduled for August 19, 2025 [3] Group 2 - Monteverde & Associates PC is a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court [4] - The firm emphasizes that no company, director, or officer is above the law, encouraging shareholders with concerns to reach out for additional information [5]
$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of CARGO Therapeutics, Inc. (NASDAQ: CRGX)
GlobeNewswire News Room· 2025-07-09 16:20
Core Viewpoint - The article discusses the investigation by Monteverde & Associates PC into the acquisition of CARGO Therapeutics, Inc. by Concentra Biosciences, LLC, focusing on the fairness of the deal which includes a cash payment and contingent value rights for shareholders [1]. Group 1: Company Overview - CARGO Therapeutics, Inc. is being sold to Concentra Biosciences, LLC for $4.379 in cash per share, along with a non-transferable contingent value right [1]. - The contingent value right entitles shareholders to receive 100% of CARGO's closing net cash exceeding $217.5 million and 80% of net proceeds from the sale or licensing of specific CAR T therapies within two years post-closing [1]. Group 2: Legal Firm Background - Monteverde & Associates PC is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report and has a successful track record in recovering money for shareholders [1]. - The firm operates from the Empire State Building in New York City and specializes in class action securities litigation [2].